United Therapeutics (UTHR) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
United Therapeutics Corporation  (NASDAQ: UTHR)
 

United Therapeutics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

United Therapeutics Corporation inventory turnover ratio, the United Therapeutics Corporation's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 2.41 in the first quarter 2026, UTHR's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the United Therapeutics in Mar 31 2026 quarter, has decreased to 151 days, compare to 165 days, in the Dec 31 2025 quarter.

Within Healthcare sector 159 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 540, from total ranking in the fourth quarter 2025 at 681.

UTHR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is United Therapeutics Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UTHR Inventory Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 7.8 % 15.96 % 20.31 % 23.96 % 37.6 %
Y / Y Cost of Sales Growth 44.22 % 36.23 % 21.42 % 12.6 % 26.89 %
Inventory Turnover Ratio (TTM) 2.41 2.21 2.13 2.12 2.17
UTHR's Total Ranking # 540 # 681 # 681 # 430 # 1070
Average inventory processing period 152 165 171 172 168
Seq. Inventory Growth -2.62 % 3.74 % 4.31 % 2.3 % 4.75 %
Seq. Cost of Sales Growth 29.01 % 2.48 % 15.18 % -5.3 % 21.87 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 42
Healthcare Sector # 160
Overall Market # 540

Inventory Turnover Ratio Statistics
High Average Low
3.04 1.72 0.6
(Sep 30 2013)   (Mar 31 2016)



UTHR Company Profile >> Back to UTHR Efficiency Comparisons >> Compare UTHR Inventory Turnover Ratio to its Competitors

Financial Statements
United Therapeutics's Inventories $ 178 Millions Visit UTHR's Balance sheet
United Therapeutics's Cost of Revenues TTM $ 425 Millions Visit UTHR's Income Statement
What are UTHR's Sales? Visit UTHR's Sales by Segment

Other Inventory Turnover Ratios
United Therapeutics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
UTHR's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for UTHR's Competitors
Inventory Turnover Ratio for UTHR's Suppliers
Inventory Turnover Ratio for UTHR's Customers

You may also want to know
UTHR's Sales Growth Rates UTHR's Pe Price to earnings ratio UTHR's Receivables Turnover Ratio UTHR's Stock Quote
UTHR's Net Income Growth Rates UTHR's Ps Price to Sales ratio UTHR's Sales per Employee UTHR's Asset Turnover Ratio
UTHR's Net Margin UTHR's Pb Price to Book ratio UTHR's Financial Strength Ratios UTHR's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Vanda Pharmaceuticals Inc   6.54 $ 12.682  Millions$ 2  Millions
Twist Bioscience Corporation  6.50 $ 196.251  Millions$ 30  Millions
Phathom Pharmaceuticals Inc   6.48 $ 30.871  Millions$ 5  Millions
Precision Optics Corporation Inc   6.47 $ 24.932  Millions$ 4  Millions
Nuo Therapeutics Inc   6.42 $ 1.331  Millions$ 0  Millions
Collegium Pharmaceutical Inc   6.41 $ 256.071  Millions$ 40  Millions
Veracyte Inc   6.05 $ 132.000  Millions$ 22  Millions
Kewaunee Scientific Corporation  5.98 $ 200.155  Millions$ 33  Millions
Adm Tronics Unlimited Inc   5.93 $ 1.992  Millions$ 0  Millions
Align Technology inc   5.81 $ 1,327.000  Millions$ 228  Millions
Transmedics Group Inc   5.71 $ 260.151  Millions$ 46  Millions
Opko Health Inc   5.69 $ 372.048  Millions$ 65  Millions
Avantor Inc   5.55 $ 4,447.000  Millions$ 801  Millions
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions

Date modified: 2026-08-29T17:17:23+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.